"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"
- 1:45 pm on Friday, October 12, 2012
- 2:45 pm on Friday, October 12, 2012
- 670 Albany Street Room #107/108
Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD Director of Developmental Therapeutics Massachusetts General Hospital Cancer Center Harvard Medical School